GPN Vaccines, Inc.
Biotechnology company · Wilmington, Delaware, United States
GPN Vaccines, Inc. is a biotechnology company headquartered in Wilmington, Delaware, United States. Its earliest recorded incorporation is in 2025. It has reported private securities offerings to the US SEC, most recently $3.5 million sold in a notice filed in 2026.
GPN Vaccines at a glance
What does GPN Vaccines do?
Private fundraising reported to the SEC
1 Form D notice; the most recent reported $3.5 million sold (2026).
Frequently asked questions about GPN Vaccines
Where is GPN Vaccines headquartered?
GPN Vaccines, Inc. is headquartered in Wilmington, Delaware, United States.
What does GPN Vaccines do?
GPN Vaccines, Inc. is a biotechnology company.
When was GPN Vaccines founded?
The earliest incorporation on record for GPN Vaccines, Inc. is in 2025, according to public company registers.
Similar companies
- Inhibikase Therapeutics, Inc.Wilmington, Delaware, United States
- OpiAID, LLCWilmington, North Carolina, United States
- Synnovation Therapeutics, Inc.Wilmington, Delaware, United States
- Treadwell CorporationWilmington, North Carolina, United States
- NiKang Therapeutics, Inc.Wilmington, Delaware, United States
- Advanced Materials Technology, Inc.Wilmington, Delaware, United States
- Compact Membrane Systems, Inc.Wilmington, Delaware, United States
- StimuSIL, Inc.Wilmington, Delaware, United States
Need a CRO or CDMO for your next study?
Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.
Compare quotesLast updated 2026-09-23. Data licences